Studies presented at AAIC 2019 provide potential treatment methods for the improvement of sleep quality in individuals with dementia.
Browsing: Cognitive/neurodegenerative disorders
New studies reported at AAIC 2019 are addressing the evolving and expanding role of technology in dementia care, prevention and alleviating burden.
New research into the LGBT community and risk of dementia have been reported at AAIC 2019, highlighting that the LGBT community may have a higher risk of cognitive decline.
Studies reported at AAIC 2019 have demonstrated the links between lifestyle factors and dementia; this information could provide new insight into the best ways to alleviate the likelihood of developing the disease.
Androgen deprivation therapy has been associated with a higher likelihood of developing dementia in men with prostate cancer when compared with individuals who are not exposed to the treatment.
Recent research at EAN 2019 suggests that the loss of ability to find one’s way, to keep track of time and to create and retrieve memories may all be hallmarks of Alzheimer’s disease.
A recently published study has suggested that certain anticholinergic medications, such as antidepressants and epilepsy drugs, may increase the risks of dementia later in life.
Nilvadipine has been demonstrated to increase blood flow to the hippocampus among people with Alzheimer’s disease, according to a recent study.
Researchers have found that the sleep history and pattern of older men and women may predict the accumulation of proteins associated with Alzheimer’s disease.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.